Ann Lab Med.  2015 Jul;35(4):458-462. 10.3343/alm.2015.35.4.458.

Biochemical and Genetic Analysis of Seven Korean Individuals With Suspected Metachromatic Leukodystrophy

Affiliations
  • 1Department of Laboratory Medicine, Seoul National University College of Medicine, Seoul, Korea. songjhcp@snu.ac.kr
  • 2Department of Laboratory Medicine, Seoul National University Hospital, Seoul, Korea.
  • 3Department of Laboratory Medicine, Seoul National University Bundang Hospital, Seongnam, Korea.
  • 4Department of Pediatrics, Pusan National University Children's Hospital, Pusan National University School of Medicine, Yangsan, Korea.
  • 5Department of Pediatrics, Korea University College of Medicine, Seoul, Korea.
  • 6Department of Laboratory Medicine & Genetics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.

Abstract

Metachromatic leukodystrophy (MLD) is an autosomal recessive disease caused by a deficiency in arylsulfatase A (ARSA). However, decreased ARSA activity is also observed in pseudodeficiency (PD). To distinguish between MLD and PD, we performed gene mutation and sulfatide analyses by using dried blood spots (DBSs) from seven Korean individuals who underwent an analysis of ARSA activity. DNA was extracted from DBSs, and PCR-direct sequencing of ARSA was performed. The cDNA obtained was analyzed to confirm a novel mutation. Of the seven subjects, three were confirmed as having MLD, one was confirmed as having MLD-PD, one was confirmed as having PD, and the remaining two were obligate heterozygotes. We verified the novel pathogenic variant c.1107+1delG by performing familial and cDNA analyses. Sulfatide concentrations in DBSs were analyzed and were quantified by using ultra-performance liquid chromatography and tandem mass spectrometry, respectively. Total sulfatide concentration was inversely correlated with ARSA activity (Spearman's coefficient of rank correlation, P=0.929, P=0.0025). The results of this mutational and biochemical study on MLD will increase our understanding of the genetic characteristics of MLD in Koreans.

Keyword

Metachromatic leukodystrophy; Arylsulfatase A; Pseudodeficiency; Genetic mutation

MeSH Terms

Cerebroside-Sulfatase
Chromatography, Liquid
DNA
DNA, Complementary
Heterozygote
Leukodystrophy, Metachromatic*
Tandem Mass Spectrometry
Cerebroside-Sulfatase
DNA
DNA, Complementary

Figure

  • Fig. 1 Mutational analysis of the novel pathogenic variant of ARSA. (A) Direct sequencing of DNA from the patient (A-a) showing homozygous peaks with a G deletion at the splicing donor site in intron 6 (c.1107+1delG) in contrast to the overlapping peaks due to a heterozygous G deletion in the electropherograms of DNA from the patient's father (A-b) and mother (A-c). (B) Schematic diagram of ARSA with an alternatively spliced region in exon 6 caused by a G deletion in the splicing donor site of intron 6 (c.1107+1delG). (C) Direct sequencing of DNA from the patient (C-a) showing homozygous peaks with a G deletion in exons 6 to 7 in contrast to the overlapping peaks due to a heterozygous deletion in the patient's father (C-b) and mother (C-c).


Cited by  1 articles

A Korean Patient with Early Juvenile Form of Metachromatic Leukodystrophy: Biochemical and Molecular Genetic Investigation
Yeong-Bin Kim, Hyung-Doo Park, Rihwa Choi, Soo-Youn Lee, Chang-Seok Ki, Junghan Song, Jong-Won Kim, Jeehun Lee
Lab Med Online. 2017;7(1):41-44.    doi: 10.3343/lmo.2017.7.1.41.


Reference

1. Tan MA, Fuller M, Zabidi-Hussin ZA, Hopwood JJ, Meikle PJ. Biochemical profiling to predict disease severity in metachromatic leukodystrophy. Mol Genet Metab. 2010; 99:142–148. PMID: 19815439.
Article
2. Gieselmann V, Krägeloh-Mann I. Metachromatic leukodystrophy--an update. Neuropediatrics. 2010; 41:1–6. PMID: 20571983.
3. Baum H, Dodgson KS, Spencer B. The assay of arylsulphatases A and B in human urine. Clin Chim Acta. 1959; 4:453–455. PMID: 13663253.
Article
4. Human gene mutation database-Professional 2014.1. "HGMD Mutation Result,". Accessed on Apr 24, 2015. https://portal.biobase-international.com/hgmd/pro/allmut.php.
5. Fluharty AL. GeneReviews-Arylsulfatase A Deficiency. Updated on Aug 25, 2011. Accessed on Apr 24, 2015. http://www.ncbi.nlm.nih.gov/books/NBK1130/.
6. Berger J, Löschl B, Bernheimer H, Lugowska A, Tylki-Szymanska A, Gieselmann V, et al. Occurrence, distribution, and phenotype of arylsulfatase A mutations in patients with metachromatic leukodystrophy. Am J Med Genet. 1997; 69:335–340. PMID: 9096767.
Article
7. Fluharty AL, Fluharty CB, Bohne W, von Figura K, Gieselmann V. Two new arylsulfatase A (ARSA) mutations in a juvenile metachromatic leukodystrophy (MLD) patient. Am J Hum Genet. 1991; 49:1340–1350. PMID: 1684088.
8. Eto Y, Kawame H, Hasegawa Y, Ohashi T, Ida H, Tokoro T. Molecular characteristics in Japanese patients with lipidosis: novel mutations in metachromatic leukodystrophy and Gaucher disease. Mol Cell Biochem. 1993; 119:179–184. PMID: 8455580.
Article
9. Kang DH, Lee DH, Hong YH, Lee ST, Jeon BR, Lee YK, et al. Identification of a novel splicing mutation in the ARSA gene in a patient with late-infantile form of metachromatic leukodystrophy. Korean J Lab Med. 2010; 30:516–520. PMID: 20890085.
10. Kang SY, Yum MS, Choi HW, Lee EH, Ko TS, Yoo HW. Clinical manifestations of leukodystrophies: a single center study. J Korean Child Neurol Soc. 2011; 19:115–123.
11. Lee JH, Min KB, Lee YM, Kang HC, Lee JS, Kim HD. A case of metachromatic leukodystrophy confirmed by molecular genetic analysis. J Korean Child Neurol Soc. 2011; 19:272–276.
12. Han M, Jun SH, Song SH, Park HD, Park KU, Song J. Ultra-performance liquid chromatography/tandem mass spectrometry for determination of sulfatides in dried blood spots from patients with metachromatic leukodystrophy. Rapid Commun Mass Spectrom. 2014; 28:587–594. PMID: 24519821.
Article
13. Human Genome Variation Society. Nomenclature for the description of sequence variants. Accessed on Apr 24, 2015. http://www.hgvs.org/mutnomen/.
14. Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015; (doi: 10.1038/gim.2015.30.).
Article
15. Regis S, Corsolini F, Stroppiano M, Cusano R, Filocamo M. Contribution of arylsulfatase A mutations located on the same allele to enzyme activity reduction and metachromatic leukodystrophy severity. Hum Genet. 2002; 110:351–355. PMID: 11941485.
Article
16. Gieselmann V, Polten A, Kreysing J, von Figura K. Arylsulfatase A pseudodeficiency: loss of a polyadenylylation signal and N-glycosylation site. Proc Natl Acad Sci USA. 1989; 86:9436–9440. PMID: 2574462.
Article
17. Ricketts MH, Amsterdam JD, Park DS, Yang RS, Poretz RD, Zhang X, et al. A novel arylsulfatase A protein variant and genotype in two patients with major depression. J Affect Disord. 1996; 40:137–147. PMID: 8897113.
Article
Full Text Links
  • ALM
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr